SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

NCT00006361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Carcinoma of Unknown Primary
Head and Neck Cancer
Non-melanomatous Skin Cancer

Interventions

DRUG: semaxanib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]